Advertisement
Screener

KALA BIO, INC. (KALA) Operating Lease, Liability, Current

2.8 / 5 stars · 68/120 Roast Me

KALA BIO, INC. Operating Lease, Liability, Current

KALA BIO, INC. (KALA) had Operating Lease, Liability, Current of $420.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-19.

Financial Statements › Notes › Leases

us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-04-15

  • 2025-09-30: Operating Lease, Liability, Current $420.00K.
  • 2025-06-30: Operating Lease, Liability, Current $406.00K.
  • 2025-03-31: Operating Lease, Liability, Current $393.00K.
  • 2024-12-31: Operating Lease, Liability, Current $380.00K.
Period endOperating Lease, Liability, Current
2025-09-30$420.00K
10-Q · filed 2025-11-19
2025-06-30$406.00K
10-Q · filed 2025-08-08
2025-03-31$393.00K
10-Q · filed 2025-05-14
2024-12-31$380.00K
10-K · filed 2026-04-15
2024-09-30$368.00K
10-Q · filed 2024-11-12
2024-06-30$356.00K
10-Q · filed 2024-08-06
2024-03-31$345.00K
10-Q · filed 2024-05-14
2023-12-31$334.00K
10-K · filed 2025-03-31
2023-09-30$324.00K
10-Q · filed 2023-11-13
2023-03-31$3.00K
10-Q · filed 2023-05-09
2022-12-31$13.00K
10-K · filed 2024-03-29
2022-09-30$32.00K
10-Q · filed 2022-11-08
2022-06-30$52.00K
10-Q · filed 2022-08-11
2022-03-31$625.00K
10-Q · filed 2022-05-16
2021-12-31$711.00K
10-K · filed 2023-03-03
2021-09-30$1.89M
10-Q · filed 2021-11-15
2021-06-30$1.98M
10-Q · filed 2021-08-05
2021-03-31$1.99M
10-Q · filed 2021-05-05
2020-12-31$1.53M
10-K · filed 2022-03-29
2020-09-30$1.48M
10-Q · filed 2020-11-05
2020-06-30$1.43M
10-Q · filed 2020-08-06
2020-03-31$1.38M
10-Q · filed 2020-05-07
2019-12-31$1.33M
10-K · filed 2021-02-25
2019-09-30$1.28M
10-Q · filed 2019-11-07
2019-06-30$1.63M
10-Q · filed 2019-08-06
2019-03-31$1.62M
10-Q · filed 2019-05-09
2018-12-31$463.00K
10-K · filed 2020-02-12
2018-09-30$101.00K
10-Q · filed 2018-11-08
2018-06-30$202.00K
10-Q · filed 2018-08-09
2018-03-31$300.00K
10-Q · filed 2018-05-10
2017-12-31$397.00K
10-K · filed 2019-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
MetaVia Inc. (MTVA)United States$0.011B-0.65
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Dare Bioscience, Inc. (DARE)United States$0.011B
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92